J&J Vaccine - Pandemic Will Be Over Soon | drbeen
Author declares no conflict of interest.
Get free trial
with access to all our lectures
DrBeen Logo

no credit card required

My Notes

Become a member to create study notes.
Sign up for free trial
J&J Vaccine - Pandemic Will Be Over Soon Duration: 752
Microbiology / Virology

Learning Objectives

In this talk, we will discuss the following topics:
Johnson and Johnson's vaccine is different from others because it is a single-shot vaccine.
Phase III trial interim results of the J&J vaccines showing
a) 100% protection from COVID related deaths
b) 85% protection from the severe COVID disease
c) 66% overall efficacy
Countries in which the vaccine trial is conducted
The reason for lesser efficacy in South Africa
Side effects are similar to a placebo that is not too bad

Instructor

Dr. Mobeen Syed

Dr. Mobeen Syed

Mobeen Syed M.D, MS Graduated from King Edward Medical University. Entrepreneur, Medical Educator, CEO and founder of Drbeen corp.


Videos in this series